triazoles has been researched along with Claustrophobia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunck, M; Gaburro, S; Hauschild, M; Landgraf, R; Sartori, SB; Singewald, N | 1 |
| Bennett, M; Chokka, P; Johnston, D; Kjernisted, K; Mancini, C; Oakman, J; Patterson, B; Van Ameringen, M; Walker, J | 1 |
| Arriola, E; Dowsett, M; Hui, E; Smith, IE | 1 |
| Benazzi, F | 1 |
| Fones, CS; Otto, MW; Pollack, MH; Worthington, JJ; Zucker, BG | 1 |
| Mancini, C; Oakman, JM; Van Ameringen, M | 1 |
| Roberts-Thompson, IC; Schrader, GD | 1 |
| Farvolden, P; Mancini, C; Oakman, JM; Van Ameringen, M | 1 |
3 trial(s) available for triazoles and Claustrophobia
| Article | Year |
|---|---|
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Female; Humans; Male; Phobic Disorders; Piperazines; Treatment Outcome; Triazoles | 2007 |
Nefazodone for social phobia: a clinical case series.
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Phobic Disorders; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles | 1998 |
Nefazodone in social phobia.
Topics: Adult; Antidepressive Agents, Second-Generation; Drug Administration Schedule; Female; Humans; Male; Phobic Disorders; Piperazines; Psychiatric Status Rating Scales; Serotonin Agents; Treatment Outcome; Triazoles | 1999 |
5 other study(ies) available for triazoles and Claustrophobia
| Article | Year |
|---|---|
Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Corticosterone; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Expressed Emotion; Fear; Fluorobenzenes; Male; Mice; Neurokinin-1 Receptor Antagonists; Phobic Disorders; Physical Conditioning, Animal; Piperidines; Psychopathology; Triazoles; Up-Regulation | 2011 |
Aromatase inhibitors and male breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyproterone Acetate; Estradiol; Estrogens; Estrogens, Conjugated (USP); Humans; Letrozole; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Phobic Disorders; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Spinal Neoplasms; Testosterone; Treatment Outcome; Triazoles | 2007 |
Nefazodone withdrawal symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Phobic Disorders; Piperazines; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Triazoles | 1998 |
Adverse effect of nefazodone: hepatitis.
Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Depression; Humans; Male; Phobic Disorders; Piperazines; Triazoles | 1999 |
Serotonergic agents in the treatment of social phobia in children and adolescents: a case series.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Female; Humans; Male; Paroxetine; Phobic Disorders; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Triazoles | 1999 |